32 Slides Presentation Deck

Oncology Platform Overview Deck

Presentation-ready overview of ArcaScience's AI-driven benefit-risk analysis capabilities for oncology, designed for oncology drug safety leads, regulatory affairs teams, and clinical development executives.

Download Slide Deck

What's Inside

A 32-slide deck covering the full ArcaScience platform configured for oncology, from data coverage through regulatory outputs. Ready for internal presentations, steering committees, and vendor evaluations.

01

Oncology BRA landscape overview

02

irAE detection and classification

03

Checkpoint inhibitor comparative safety

04

Targeted therapy benefit modeling

05

Combination regimen risk assessment

06

REMS program automation

07

Accelerated approval BRA templates

08

Post-marketing surveillance dashboards

Featured Slide Previews

irAE Pattern Detection

Automated identification and grading of immune-related adverse events across organ systems, with temporal pattern analysis and cross-class comparisons...

Tumor-Agnostic BRA

Framework for benefit-risk assessment of tissue-agnostic approvals, integrating biomarker-defined populations across multiple tumor types into a unifi...

Combination Therapy Modeling

Quantitative risk assessment for multi-agent oncology regimens, distinguishing additive from synergistic toxicity profiles and modeling dose-response ...

Get the Full Oncology Platform Overview Deck

Complete the form below to receive the document via email.

By downloading, you agree to our Privacy Policy.

More Oncology Resources

PDF Whitepaper

Oncology BRA Methodology Guide

Case Studies

Oncology Case Study Collection

Regulatory Guide

Oncology Regulatory Landscape

See ArcaScience for Oncology

Request a live demonstration of ArcaScience configured for oncology benefit-risk analysis. Our scientists will show TA-specific data, AI models, and regulatory outputs relevant to your program.

Request Oncology Demo